Skip to main content
Caplight Logo









Validose

Validose

Private
New York City, New YorkHealthcare & Life Scienceshttps://validose.com/

Last Round

Pre Seed

Feb 18, 2025

Total Funding Raised

$2M

Company Overview

Validose is a healthtech company that provides a medication adherence platform using a smart dosing device and real-time data to improve patient outcomes in clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Medical Devices, Patient Engagement, Health IoT, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

medication adherenceclinical trial softwaredigital healthsmart pill bottlepatient monitoringmedtechhealth IoTclinical trial technologyremote patient monitoringRPMbehavioral coachinghealthcare analyticshardware-as-a-serviceHaaSconnected health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Validose Comparables

Compare Validose with similar companies based on industry and business-model similarity.

Validose comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Pill Connect Limited
88%
Information Mediary Corp.
78%
AARDEX Group
77%

Validose Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedFeb 18, 2025

Key People

Founding team and executive leadership

Paul McGrath

Chief Executive Officer

Executive Team

Validose Investors

Notable investors and investment history

Validose investors
InvestorRounds
10XBetaPre Seed
Interstate Fusion VenturesPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 18, 2025

    $2M raised in Pre Seed round.

Validose Filings

Explore SEC and related filing metadata, where available.

Validose filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Validose's valuation, stock price, and market status.

Is Validose a public or private company?

Validose is a private company.

What is the current stock price of Validose?

Validose is a private company with no public stock price. No recent secondary market data is available.

How much is Validose worth (valuation)?

Valuation information for Validose is not publicly available.

Can I buy Validose stock?

Validose shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Validose's last funding round?

Validose's most recent funding round was Pre Seed on February 18, 2025.

Who are the main investors in Validose?

Key investors in Validose include 10XBeta, Interstate Fusion Ventures.

Will Validose IPO soon?

No public IPO plans have been announced for Validose.

How can I track Validose secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Validose's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range5
Year Founded2024
Last FundingFeb 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?